FDA Investigator Adetutu M Gidado

Adetutu M Gidado has inspections in 11 countries as of 10 Nov 2023. Adetutu M Gidado has collaborated with a combinined 4251 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
75
Last Inspection Date:
10 Nov 2023
Investigator Role:
FDA Investigator
Redica ID:
100005596
Country:
United States of America, India, Taiwan, Ireland, Denmark, Canada, Switzerland, Austria, Mexico, Costa Rica, Poland
Co-Investigator(s):
Adam R Cooke, Addam S Reynolds, Alan P Kurtzberg, Alberto A Viciedo, Alice S Tsao, Amy L Singer, Amy M Codella, Amy M Cramer, Ana P Pineda Zavaleta, Anastasia M Shields, Anita R Michael, Ankur C Patel, Ann Marie Montemurro, Ann Marie Schofield, Anne E Johnson, Annemarie B Randow, Annemarie Bodnar, Annet R Rajan, Anthony C Warchut, Ashutosh Rao, PhD, Atul J Agrawal, Barbara J Wilimczyk, Barbara Janine Breithaupt, Barbara Jwilimczyk Macri, Brian D Nicholson, Bryan L Mcguckin, Cassandra L Abellard, CDR Rochelle B Young, RPh, MSA, Cheryl A Clausen, Claire M Minden, Craig D Zagata, Cynthia Jim, CSO, Daniel J Grabicki, Daniel J Min, Daniel J Roberts, David A Oluwo, Dawn L Wydner, Denise M Digiulio, Denise M Visco, Investigator, Devon Jenkins, Dhaval H Patel, Diane C Thibodeau, Dien N Nguyen, Djamila Harouaka, Donald C Obenhuber, PhD, Dorothy J Denes, Douglas C Kovacs, Dr. Robert C Horan, MD, Edmund F Mrak, Jr, Elaine E Gilfillan, Emest F Bizjak, Emmanuel J Ramos, Eric M Mueller, PharmD, Erika V Butler, Erin D Mccaffery, Esteban Beltran, Felix Maldonado, Ferderick Razzaghi, Frank J Marciniak, Fred Razzaghi, Frederick Razzaghi, Gayle S Lawson, Gerald B Seaborn, Jr, Gobiga Vanniyasingam, Gregson A Joseph, Guerlain Ulysse, Gwyn G Dickinson, Hala L Selby, Harperd, Helen B Ricalde, Helen Verdel, Himanshu Gupta, PhD, James A Liubicich, James D Bridges, James M Mason, James R Birkenstamm, Janet A Rajan, Javier E Santos, Jay B Shah, Jennifer L Custodio, Jennifer Macmillan, Jessica M Monteiro, Jogy George, John A Gonzalez, Jonah S Ufferfilge, Jonathan G Matrisciano, Jonathan S Helfgott, Jonee J Mearns, Jose Acruz Gonzalez, Jose E Melendez, DDC, Jose M Cayuela, Jose Martinez, Jr, Jose O Hernandez, Jose R Hernandez, Joseph F Mcginnis, RPh, Joseph Mcginnis, Josh Renzon Ramilo, Jot R Klena, Joy Rkozlowski Klena, Juanita P Versace, Julianne C Mccullough, Julie D Bringger, Junho Pak, Justine Tomasso, Kalavati Suvarna, PhD, Karen E D'orazio, Karishma G Gopaul, Karishma Gopaul, Katherine Szestypalow, Kelli F Dobilas, Kelly N Kerr, Kendra L Brooks, Kenneth M Gordon, Kevin P Foley, Kim Lthomas Cruse, Ko U Min, Kristen D Evans, Kristen E Rescigno, Kristina L Conroy, Kristy A Zielny, Lakshmi Narasimhan, PhD, Larry K Austin, Lata C Mathew, PhD, Laura Fontan, MS, Lauren L Vajo, Li Li, Liatte Kreuger, PharmD, Loretta Nemchik, Lourdes Valentin Aponte, Lucas B Leake, Luis A Dasta, Marcelo O Mangalindan, Jr, Marea K Harmon, Margaret M Annes, Margaret M Sands, Margaret Sand, Maria Estrella, Mark R Mcclain, Marybet Lopez, Mathew T Thomas, MD, Matthew R Dionne, Maya M Davis, Melissa J Garcia, Melissa T Roy, Meredith L Sheridan, Meyer J Slobotsky, Michael A Charles, Michael E Maselli, Michael R Klapal, Michael Serrano, Miguel A Martinez, Mina D Ahmadi, Mindy M Chou, Morea K Harmen, Nadeem I Chaudhry, Nancy F Scheraga, Nancy L Rolli, Nancy M Espinal, Nancy Sheraga, Natasha Gupta, Nealie C Newberger, Nerizza B Guerin, Nicholas A Violand, Niketa Patel, Nikisha M Bolden, Nina Yang, Odera I Ekwunife, Parul M Patel, Patricia Fhughes Troost, Patrick C Klotzbuecher, Patsy J Domingo, Paul L Bellamy, Paul L Figarole, Jr, Paula J Bretz, Peter R Lenahan, Pratibha Bhat, Pushpa S Jayasekara, Rafael Nevarez Nieves, Reba A Gates, Rebecca Rodriguez, Regina T Brown, Reyes Candau Chacon, PhD, Richard E Needham, Richard Ledwidge (nmi), PhD, Robert J Martin, Robert W Jennings, Robin P Mathew, Rochelle K Kimmel, Ronald G Crawford, Rose Ljean Mary, Rose M Ashley, Russell J Glapion, Saleem A Akhtar, Samir C Gala, Sandra A Boyd, Sarah Adella Fave, Sarah Forney, Satheesh K Podaralla, Sayyem H Akbar, Scott T Ballard, Sean G Casey, Sena G Dissmeyer, Sharon K Thoma, PharmD, Shirley S Wen, Sixto M Mercado Rios, Srinivas R Chennamaneni, PhD, Stelios C Tsinontides, Stephanie T Durso, Stephen J Koniers, Stephen J Mottola, Steven D Kehoe, Susan M Halsted, Susan Yu, Susant Hadman, Tamil Arasu, PhD, Tanya R Syffrard, Tara G Bizjak, Tara R Gooen, Thomas E Friel, Torrance J Slayton, Toyin B Oladimeji, Truong Xuan Nguyen (Andy), Unnee Ranjan, Victoria Spivak, Vilmary Negron Rodriguez, Vlada Matusovsky, Wayne D Mcgrath, William Chang, William R Chang, Xiaohan Cai, PhD, Yiyue Zhang (nmi), PhD, Yong Wu, PhD, Yvesna C Blaise, Yvins Dezan, Zhong Li, PhD

Adetutu M Gidado's Documents

Publish Date Document Type Title
January, 2020 EIR HOVIONE LLC - EIR, 2020-01-22
April, 2016 FDA 483 Response Akorn Operating Company LLC (dba Akorn) - Form 483R, 2016-04-26
May, 2019 FDA 483 A.P. Deauville, LLC - Form 483, 2019-05-02
May, 2018 FDA 483 Advanced Accelerator Applications USA, Inc. - Form 483, 2018-05-17
July, 2016 FDA 483 Actavis LLC - Form 483, 2016-07-07
June, 2023 FDA 483 Renaissance Lakewood LLC - Form 483, 2023-06-06
June, 2017 EIR InvaDerm Corporation - EIR, 2017-06-15
October, 2018 FDA 483 Response Endo Pharmaceuticals Solutions Inc. - Form 483R, 2018-11-08
June, 2021 FDA 483 Tris Pharma Inc - Form 483, 2021-06-08
July, 2018 FDA 483 Genus Lifesciences Inc. - Form 483, 2018-07-20
March, 2019 FDA 483 InvaDerm Corporation - Form 483, 2019-03-26
July, 2016 EIR Actavis LLC - EIR, 2016-07-07
January, 2017 FDA 483 Cosette Pharmaceuticals, Inc. - Form 483, 2017-01-26
September, 2017 FDA 483 HK Kolmar Canada, Inc - Form 483, 2017-09-29
April, 2016 FDA 483 Alliance Technologies, LLC - Form 483, 2016-04-15
March, 2018 FDA 483 Sun Pharmaceutical Industries, Inc. - Form 483, 2018-03-09
February, 2019 FDA 483 Compañía Internacional de Comercio, S.A.P.I. de C.V. - Form 483, 2019-02-01
September, 2016 FDA 483 Response New Jersey Laboratories - Form 483R, 2016-10-11
March, 2023 FDA 483 EzriCare, LLC. - Form 483, 2023-03-21
October, 2018 FDA 483 Endo Pharmaceuticals Solutions Inc. - Form 483, 2018-12-10
January, 2019 EIR Productos Quimicos Naturales S.A. de C.V. - EIR, 2019-01-25
January, 2020 FDA 483 HOVIONE LLC - Form 483, 2020-01-22
July, 2017 EIR Amneal Pharmaceuticals, LLC - EIR, 2017-07-27
November, 2021 FDA 483 Suite K Value Added Services LLC - Form 483, 2021-11-02
March, 2017 FDA 483 Response Tris Pharma Inc - Form 483R, 2017-03-20
July, 2017 FDA 483 Amneal Pharmaceuticals, LLC - Form 483, 2017-07-27
December, 2016 FDA 483 Guardian Drug Company - Form 483, 2016-12-06
February, 2019 FDA 483 Polimeros y Servicios S.A. - Form 483, 2019-02-15
September, 2022 FDA 483 A/S Orthana Kemisk Fabrik - Form 483, 2022-10-21
December, 2019 FDA 483 Tulex Pharmaceuticals Inc - Form 483, 2019-12-12
December, 2021 FDA 483 INVAHEALTH INC. - Form 483, 2021-12-15
April, 2016 FDA 483 Akorn Operating Company LLC (dba Akorn) - Form 483, 2016-04-04
June, 2023 EIR Renaissance Lakewood LLC - EIR, 2023-06-06
March, 2017 FDA 483 Tris Pharma Inc - Form 483, 2017-03-20
September, 2021 FDA 483 Premier Trends LLC - Form 483, 2021-09-29
November, 2019 EIR Camber Pharmaceuticals, Inc. - EIR, 2019-11-25
December, 2015 FDA 483 L'OREAL USA, INC. - Form 483, 2015-12-09
March, 2022 FDA 483 Novel Laboratories, Inc. - Form 483, 2022-03-30
January, 2016 FDA 483 Davlyn Industries Inc. - Form 483, 2016-01-11
May, 2017 EIR InvaDerm Corporation - EIR, 2017-05-30
November, 2022 FDA 483 HOVIONE LLC - Form 483, 2022-11-17
August, 2020 EIR Kobo Products, Inc - EIR, 2020-08-18
March, 2016 FDA 483 SPECTRUM LABORATORY PRODUCTS INC. dba SPECTRUM CHEMICAL MFG. CORP. - Form 483, 2016-03-14
June, 2022 FDA 483 Mandell's Clinical Pharmacy - Form 483, 2022-06-17
August, 2021 FDA 483 Water-Jel Technologies - Form 483, 2021-08-18
September, 2016 EIR New Jersey Laboratories - EIR, 2016-09-23
October, 2019 FDA 483 Milbar Laboratories, Inc. - Form 483, 2019-10-11
March, 2018 EIR Sun Pharmaceutical Industries, Inc. - EIR, 2018-03-09
August, 2020 FDA 483 Kobo Products, Inc - Form 483, 2020-08-18
June, 2018 FDA 483 Aurolife Pharma LLC - Form 483, 2018-06-14
July, 2016 FDA 483 Response Actavis LLC - Form 483R, 2016-07-28
May, 2022 FDA 483 Vantage Specialty Ingredients, Inc - Form 483, 2022-05-02
July, 2019 FDA 483 Unichem Laboratories Limited - Form 483, 2019-07-31
December, 2017 FDA 483 Hikma Injectables USA Inc. - Form 483, 2017-12-13
August, 2020 FDA 483 Response Kobo Products, Inc - Form 483R, 2020-08-18
September, 2016 FDA 483 New Jersey Laboratories - Form 483, 2016-09-23
September, 2022 EIR A/S Orthana Kemisk Fabrik - EIR, 2022-11-04
December, 2023 FDA 483 Primera Analytical Solutions Corporation - Form 483, 2023-12-12

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more